Clinical Trial Update: CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis

View source ↗

Summary

Completed clinical trial evaluating cardiac magnetic resonance T1 mapping for diagnosing cardiac amyloidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis
• Heart Failure
• Heart Failure with Mid-range Ejection Fraction
• Heart Failure with Preserved Ejection Fraction
• Left Ventricular Hypertrophy

Snippet

Sponsor: University of Leipzig | Conditions: Heart Failure NYHA Class II, Heart Failure NYHA Class III | Status: COMPLETED